For more see – https://www.growthrater.com/growthrater/#/summary Last trading report – IMS to end July 2015: The pill investors are being asked to swallow is a new incentive scheme that could reward the CEO with up to 7.5m new shares (via nil priced options) over the next 3 years dependent on a TSR exceeding +8% […]
Continue reading